# Hui Zhou

> Hui Zhou is a Series B investor at ConocoPhillips (Houston) backing Health Care and Biotechnology. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [ConocoPhillips](https://shizune.co/investors/profile/conocophillips)
- Location: Houston, United States
- Total investments: 2
- Last investment: Nov 2021
- Lead investor: 50%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/hui-zhou-7111989

Hui Zhou is a Series B investor at ConocoPhillips in Houston focused on Health Care and Biotechnology. Hui Zhou is the Staff Reservoir Engineer at ConocoPhillips. He attended Stanford University.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 50% |
| Biotechnology | 1 | 50% |
| Pharmaceutical | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 1 | 50% |
| Series C | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Xgene Pharmaceutical | Xgene Pharmaceutical is a pharmaceutical company. | $40M | Series C | Nov 05, 2021 |  |
| Xgene Pharmaceutical | Xgene Pharmaceutical is a pharmaceutical company. | $20M | Series B | Oct 25, 2018 |  |

2 of 2 investments shown.

## Co-investors
- [CITIC Securities](https://shizune.co/investors/profile/citic-securities) — VC Fund, 1 deal together
- [GSR United Capital](https://shizune.co/investors/profile/gsr-united-capital) — VC Fund, 1 deal together
- [Hengxu Capital](https://shizune.co/investors/profile/hengxu-capital) — VC Fund, 1 deal together
- [Neovision Capital](https://shizune.co/investors/profile/neovision-capital) — VC Fund, 1 deal together
- [Tao Capital](https://shizune.co/investors/profile/tao-capital) — VC Fund, 1 deal together
- [TF Capital](https://shizune.co/investors/profile/tf-capital) — VC Fund, 1 deal together

## About ConocoPhillips

VC Fund · Houston, United States

ConocoPhillips is an oil and gas exploration and production company in the energy industry that promotes safety, health, and environmental safety.The company's technical capability, asset quality and scale, and financial strength are unmatched among independent upstream companies and uniquely position them to compete anywhere. ConocoPhillipsis committed to the efficient and effective exploration and production of oil and natural gas. Producing oil and natural gas and getting them to market takes ingenuity, technology, and investment. Its innovative, collaborative efforts yield products that improve quality of life globally while producing economic benefits with far-reaching influence.

5 contacts available at ConocoPhillips.

| Name | Title | Profile |
| --- | --- | --- |
| Andrew Lundquist | Senior Vice President of Government | https://shizune.co/investors/profile/andrew-lundquist |
| Arjun Murti | Member of the Board of Directors | https://shizune.co/investors/profile/arjun-n-murti |
| Frank Phillips | Founder | https://shizune.co/investors/profile/frank-phillips |
| Gay Evans | Member of the Board of Directors | https://shizune.co/investors/profile/gay-huey-evans |
| Harald Norvik | Member of the Board of Directors | https://shizune.co/investors/profile/harald-j-norvik |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Hui Zhou invest in?

Hui Zhou invests primarily in Health Care, Biotechnology and Pharmaceutical startups, most often at Series B and Series C stage. Most of the 2 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Hui Zhou last invest?

The most recent investment recorded for Hui Zhou closed in Nov 2021. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co
